Nektar Therapeutics (NKTR) on Wednesday reported fourth-quarter earnings of $7.3 million. The San Francisco-based company said it had net income of 3 cents per share. Earnings, adjusted for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback